Cargando…

Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study

INTRODUCTION: Weight gain after starting antiretroviral therapy (ART) is a major problem that can increase morbidity. Our main objective was to evaluate the effects of initial ART on weight change in a large prospective cohort of HIV‐positive individuals. METHODS: This was a prospective cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez‐Sanz, Javier, Blanco, José‐Ramón, Muriel, Alfonso, Pérez‐Elías, María Jesús, Rubio‐Martín, Rafael, Berenguer, Juan, Peraire, Joaquim, Bernal, Enrique, Martínez, Onofre Juan, Serrano‐Villar, Sergio, Moreno, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150051/
https://www.ncbi.nlm.nih.gov/pubmed/34036745
http://dx.doi.org/10.1002/jia2.25732
_version_ 1783698079988318208
author Martínez‐Sanz, Javier
Blanco, José‐Ramón
Muriel, Alfonso
Pérez‐Elías, María Jesús
Rubio‐Martín, Rafael
Berenguer, Juan
Peraire, Joaquim
Bernal, Enrique
Martínez, Onofre Juan
Serrano‐Villar, Sergio
Moreno, Santiago
author_facet Martínez‐Sanz, Javier
Blanco, José‐Ramón
Muriel, Alfonso
Pérez‐Elías, María Jesús
Rubio‐Martín, Rafael
Berenguer, Juan
Peraire, Joaquim
Bernal, Enrique
Martínez, Onofre Juan
Serrano‐Villar, Sergio
Moreno, Santiago
author_sort Martínez‐Sanz, Javier
collection PubMed
description INTRODUCTION: Weight gain after starting antiretroviral therapy (ART) is a major problem that can increase morbidity. Our main objective was to evaluate the effects of initial ART on weight change in a large prospective cohort of HIV‐positive individuals. METHODS: This was a prospective cohort study of 13,198 subjects included in the Spanish HIV Research Network (CoRIS) between January 2004 and November 2018. We included subjects who started triple ART and achieved HIV RNA suppression within 48 weeks. We fitted linear mixed models adjusted for potential confounders to compare longitudinal changes in weight. We used Cox proportional‐hazard models to compare treatment groups’ times to transition to a higher body mass index (BMI) category. RESULTS: We analysed data from a total of 1631 individuals resulting in 14,965 persons/years and 14,085 observations. Individuals retained in the final multivariable model were representative of the overall cohort. NNRTI‐based first‐line ART was associated with a lower average weight gain compared to PI‐ (+0.7 kg per year, 95% CI 0.5 to 1.0, p < 0.001) and INSTI‐based (+0.9 kg per year, 95% CI 0.7 to 1.1, p < 0.001) regimens. Individuals starting ART with TAF+FTC had greater weight gain than those receiving TDF+FTC (+0.8 kg per year, 95% CI 0.3 to 1.4, p = 0.004). Women and black persons presented a greater weight gain than men and non‐black individuals. Differences in weight trajectories were driven mainly by changes during the first year of ART. The NNRTI group was less likely to transition from normal weight to overweight than the PI (aHR 1.48, 95% CI 1.18 to 1.85) and INSTI groups (aHR 1.30, 95% CI 1.03 to 1.64). PIs but not INSTIs were associated with a higher rate of overweight‐to‐obesity shift (aHR 2.17, 95% CI 1.27 to 3.72). No differences were found among INSTIs in the transition to a higher BMI category. CONCLUSIONS: INSTI‐ and PI‐based first‐line ARTs are associated with greater weight gain compared to NNRTI‐based ART. Within the NRTIs, TAF+FTC was most strongly associated with weight gain. This heterogeneous effect of ART on body weight could affect the long‐term risk of some non‐communicable diseases.
format Online
Article
Text
id pubmed-8150051
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81500512021-06-03 Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study Martínez‐Sanz, Javier Blanco, José‐Ramón Muriel, Alfonso Pérez‐Elías, María Jesús Rubio‐Martín, Rafael Berenguer, Juan Peraire, Joaquim Bernal, Enrique Martínez, Onofre Juan Serrano‐Villar, Sergio Moreno, Santiago J Int AIDS Soc Research Articles INTRODUCTION: Weight gain after starting antiretroviral therapy (ART) is a major problem that can increase morbidity. Our main objective was to evaluate the effects of initial ART on weight change in a large prospective cohort of HIV‐positive individuals. METHODS: This was a prospective cohort study of 13,198 subjects included in the Spanish HIV Research Network (CoRIS) between January 2004 and November 2018. We included subjects who started triple ART and achieved HIV RNA suppression within 48 weeks. We fitted linear mixed models adjusted for potential confounders to compare longitudinal changes in weight. We used Cox proportional‐hazard models to compare treatment groups’ times to transition to a higher body mass index (BMI) category. RESULTS: We analysed data from a total of 1631 individuals resulting in 14,965 persons/years and 14,085 observations. Individuals retained in the final multivariable model were representative of the overall cohort. NNRTI‐based first‐line ART was associated with a lower average weight gain compared to PI‐ (+0.7 kg per year, 95% CI 0.5 to 1.0, p < 0.001) and INSTI‐based (+0.9 kg per year, 95% CI 0.7 to 1.1, p < 0.001) regimens. Individuals starting ART with TAF+FTC had greater weight gain than those receiving TDF+FTC (+0.8 kg per year, 95% CI 0.3 to 1.4, p = 0.004). Women and black persons presented a greater weight gain than men and non‐black individuals. Differences in weight trajectories were driven mainly by changes during the first year of ART. The NNRTI group was less likely to transition from normal weight to overweight than the PI (aHR 1.48, 95% CI 1.18 to 1.85) and INSTI groups (aHR 1.30, 95% CI 1.03 to 1.64). PIs but not INSTIs were associated with a higher rate of overweight‐to‐obesity shift (aHR 2.17, 95% CI 1.27 to 3.72). No differences were found among INSTIs in the transition to a higher BMI category. CONCLUSIONS: INSTI‐ and PI‐based first‐line ARTs are associated with greater weight gain compared to NNRTI‐based ART. Within the NRTIs, TAF+FTC was most strongly associated with weight gain. This heterogeneous effect of ART on body weight could affect the long‐term risk of some non‐communicable diseases. John Wiley and Sons Inc. 2021-05-26 /pmc/articles/PMC8150051/ /pubmed/34036745 http://dx.doi.org/10.1002/jia2.25732 Text en © 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Martínez‐Sanz, Javier
Blanco, José‐Ramón
Muriel, Alfonso
Pérez‐Elías, María Jesús
Rubio‐Martín, Rafael
Berenguer, Juan
Peraire, Joaquim
Bernal, Enrique
Martínez, Onofre Juan
Serrano‐Villar, Sergio
Moreno, Santiago
Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study
title Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study
title_full Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study
title_fullStr Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study
title_full_unstemmed Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study
title_short Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study
title_sort weight changes after antiretroviral therapy initiation in coris (spain): a prospective multicentre cohort study
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150051/
https://www.ncbi.nlm.nih.gov/pubmed/34036745
http://dx.doi.org/10.1002/jia2.25732
work_keys_str_mv AT martinezsanzjavier weightchangesafterantiretroviraltherapyinitiationincorisspainaprospectivemulticentrecohortstudy
AT blancojoseramon weightchangesafterantiretroviraltherapyinitiationincorisspainaprospectivemulticentrecohortstudy
AT murielalfonso weightchangesafterantiretroviraltherapyinitiationincorisspainaprospectivemulticentrecohortstudy
AT perezeliasmariajesus weightchangesafterantiretroviraltherapyinitiationincorisspainaprospectivemulticentrecohortstudy
AT rubiomartinrafael weightchangesafterantiretroviraltherapyinitiationincorisspainaprospectivemulticentrecohortstudy
AT berenguerjuan weightchangesafterantiretroviraltherapyinitiationincorisspainaprospectivemulticentrecohortstudy
AT perairejoaquim weightchangesafterantiretroviraltherapyinitiationincorisspainaprospectivemulticentrecohortstudy
AT bernalenrique weightchangesafterantiretroviraltherapyinitiationincorisspainaprospectivemulticentrecohortstudy
AT martinezonofrejuan weightchangesafterantiretroviraltherapyinitiationincorisspainaprospectivemulticentrecohortstudy
AT serranovillarsergio weightchangesafterantiretroviraltherapyinitiationincorisspainaprospectivemulticentrecohortstudy
AT morenosantiago weightchangesafterantiretroviraltherapyinitiationincorisspainaprospectivemulticentrecohortstudy
AT weightchangesafterantiretroviraltherapyinitiationincorisspainaprospectivemulticentrecohortstudy